Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2333720
Max Phase: Preclinical
Molecular Formula: C22H40O7
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
ID: ALA2333720
Max Phase: Preclinical
Molecular Formula: C22H40O7
Molecular Weight: 416.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCOCCCCOC[C@H]1O[C@@H]2OC(C)(C)O[C@@H]2[C@H]2OCO[C@H]21
Standard InChI: InChI=1S/C22H40O7/c1-4-5-6-7-8-9-12-23-13-10-11-14-24-15-17-18-19(26-16-25-18)20-21(27-17)29-22(2,3)28-20/h17-21H,4-16H2,1-3H3/t17-,18+,19+,20-,21-/m1/s1
Standard InChI Key: OJNCXWXTSGTXDP-XDWAVFMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.56 | Molecular Weight (Monoisotopic): 416.2774 | AlogP: 3.78 | #Rotatable Bonds: 14 |
Polar Surface Area: 64.61 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.27 | CX LogD: 4.27 |
Aromatic Rings: 0 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: 0.72 |
1. Chaveriat L, Gosselin I, Machut C, Martin P.. (2013) Synthesis, surface tension properties and antibacterial activities of amphiphilic D-galactopyranose derivatives., 62 [PMID:23353739] [10.1016/j.ejmech.2012.12.032] |
Source(1):